Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) FCF Margin (2019 - 2025)

AVITA Medical (RCEL) has disclosed FCF Margin for 5 consecutive years, with 6.84% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 8649.0% year-over-year to 6.84%, compared with a TTM value of 15.14% through Dec 2025, up 7605.0%, and an annual FY2025 reading of 45.43%, up 4552.0% over the prior year.
  • FCF Margin was 6.84% for Q4 2025 at AVITA Medical, down from 5.5% in the prior quarter.
  • Across five years, FCF Margin topped out at 5.5% in Q3 2025 and bottomed at 198.23% in Q1 2024.
  • Average FCF Margin over 4 years is 67.9%, with a median of 60.66% recorded in 2023.
  • The sharpest move saw FCF Margin tumbled -11223bps in 2024, then skyrocketed 14135bps in 2025.
  • Year by year, FCF Margin stood at 32.65% in 2022, then crashed by -162bps to 85.45% in 2023, then dropped by -9bps to 93.33% in 2024, then soared by 93bps to 6.84% in 2025.
  • Business Quant data shows FCF Margin for RCEL at 6.84% in Q4 2025, 5.5% in Q3 2025, and 59.0% in Q2 2025.